Q3 2012 13F Holders as of 30 Sep 2012
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
1,148,777,709
-
Total 13F shares
-
1,904,934
-
Share change
-
+18,897
-
Total reported value
-
$78,886,312
-
Price per share
-
$41.41
-
Number of holders
-
10
-
Value change
-
+$803,919
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q3 2012
As of 30 Sep 2012,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,904,934 shares.
The largest 10 holders included
SHUFRO ROSE & CO LLC, AGF Investments America Inc., Dixon Mitchell Investment Counsel Inc., Zurcher Kantonalbank (Zurich Cantonalbank), HUNTINGTON NATIONAL BANK, HUNTINGTON ASSET ADVISORS, INC., MUFG Americas Holdings Corp, Northwest & Ethical Investments L.P., Baskin Financial Services Inc., and MCF Advisors LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2012 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.